Likewise, increased FAK expression has been implemented in survival of other cancer types, including breast cancer [36, 37], bladder cancer [38] and squamous cell carcinoma [39] through activation of MAPK- and PI3K-related signaling pathways [40]. Here, PTK2 is linked to urinary bladder cancer.